Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 1. Effects of 5-HT2AR agonists on ERK activation. HEK-293 cells were transfected with 5-HT2AR cDNA in pCNS-D2. Cells were treated with increasing concentrations of 5-HT, 25C-NBOMe, and methallyescaline for 5 min. 5-HT was dissolved in serum-free media; 25C-NBOMe and methallyescaline were dissolved in DMSO. *p<0.05, **p<0.01 compared with the vehicle-treated group (n=3).
Biomolecules & Therapeutics 2023;31:176~182 https://doi.org/10.4062/biomolther.2022.096
© Biomolecules & Therapeutics